ISSN: 2329-8863

Progrès dans la science et la technologie des cultures

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Indice source CAS (CASSI)
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Accès en ligne à la recherche en environnement (OARE)
  • Ouvrir la porte J
  • Clés académiques
  • JournalTOC
  • Accès à la recherche mondiale en ligne sur l'agriculture (AGORA)
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Direction des chercheurs
  • Catalogue en ligne SWB
  • Publons
  • Euro Pub
Partager cette page

Abstrait

Regulation of Genetically Modified Organisms Trade and Utilization in Developing Countries

Lenjisa Direba Balcha

Crops improved through biotechnology have been widely adopted by farmers around the world wherever farmers have been able to secure access to the seeds and where they do not fear the loss of export markets. However, governments in some regions have created significant impediments to farmers’ use of GMO-improved seeds, most conspicuously in Europe, which has exported restrictive regimes wherever they can, with particular success in sub- Saharan Africa. African farmers’ access to biotech-improved seeds has been severely and directly limited by threats from Europe to close their access to export markets; and by regulatory barriers to innovation erected through a global effort by EU and member states to create regulations in other countries that block farmers’ access to biotechimproved seeds. And on top of that, a wide array of NGOs, more interested in pursuing an anti-corporate agenda than a pro-development agenda, have worked to convince nations to ban or otherwise limit productivity-enhancing GMOs. Consequently, in most cases, seeds for GM versions of African crops simply don’t exist. Even in the few cases where biotech-improved seeds do exist, it is difficult or impossible for farmers to gain access. Despite the strongly positive track record of biotech-derived crops for farmers, consumers, and the environment, unexploited opportunities for additional, widely shared benefits are considerable. We estimate the economic value forgone in Africa from restrictive regulation at $1 billion in 2013. If such regulations continue to restrict and suppress innovation in agriculture, the cumulative costs to low- and lower-middle-income countries worldwide will be approximately $1.5 trillion by 2050. Because of the unprecedented demands to increase agricultural production and productivity over the next 30 years, such restrictive regimes must be rolled back everywhere as rapidly as possible.